SEC Form D · Amendment · filed April 30, 2021
Lengo Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Anna Chen · Menlo Park, CAExecSteve Bailey · Menlo Park, CAExecTracy Saxton, Ph.D · Menlo Park, CADirectorDaniel Estes, Ph.D · Menlo Park, CAExec · DirectorRoger Ulrich, Ph.D · Menlo Park, CADirectorDavid Laizerovich · New York, NYDirectorSoul Peter Ventures Management Ltd · New York, NYExec · DirectorChristopher Olsen · Columbus, OHDirectorSo C. On · New York, NYExecBrendon C. Lundberg · Lake Oswego, ORExecHelen Jenkins · Menlo Park, CAExec · DirectorDavid Johnson · Cambridge, MADirectorJeff Reich, Md · Birmingham, ALExec · DirectorRobert Mannherz, Md · Birmingham, ALExecNancy Easley-Mack · Birmingham, ALExecLillian Carson · Birmingham, ALDirectorEric George, Md · Birmingham, ALDirectorHelen Jenkins · Menlo Park, CAExec · DirectorDavid Johnson · St. Louis Park, MNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗